How does warfarin affect the activated coagulation time?

被引:28
作者
Chang, RJ
Doherty, TM
Goldberg, SL
机构
[1] Harbor UCLA Med Ctr, Div Cardiol, Dept Med, Torrance, CA 90509 USA
[2] St Johns Cardiovasc Res Ctr, Torrance, CA USA
关键词
D O I
10.1016/S0002-8703(98)70223-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The activated coagulation rime (ACT) is a rapid measurement of a patient's level of heparin anticoagulation during cardiac catheterization. Patients receiving warfarin therapy occasionally are seen at the catheterization laboratory for emergent procedures. The effects of warfarin on ACT activity have not been previously described. We compared the ACT and the international normalized ratios (INR) in 77 patients receiving warfarin and 57 patients who were not receiving any anticoagulation (controls). Results Both the mean ACT (131 +/- 17.0 seconds) and INR (2.5 +/- 0.90 seconds) of the anticoagulated patients differed from the controls (ACT = 115 +/- 14.5 seconds, INR = 1.0 +/- 0.10 seconds; P < 0.05). The ACT increased linearly with INR in the warfarin group (r = 0.70, P < .001). There was no relation between ACT and INR in the control group. Conclusion Patients receiving warfarin therapy will have a linear increase in ACT develop similar to patients receiving heparin therapy.
引用
收藏
页码:477 / 479
页数:3
相关论文
共 12 条
[1]  
BASHORE TM, 1994, DIAGNOSTIC THERAPEUT, P62
[2]  
Braunwald Eugene., 1997, HEART DIS, VFifth
[3]   RELATION BETWEEN PROCEDURAL ACTIVATED COAGULATION TIME AND OUTCOME AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
FERGUSON, JJ ;
DOUGHERTY, KG ;
GAOS, CM ;
BUSH, HS ;
MARSH, KC ;
LEACHMAN, DR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) :1061-1065
[4]   MECHANISM OF ACTION AND MONITORING OF ANTICOAGULANTS [J].
HIRSH, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1986, 12 (01) :1-11
[5]   GUIDE TO ANTICOAGULANT-THERAPY .1. HEPARIN [J].
HIRSH, J ;
FUSTER, V .
CIRCULATION, 1994, 89 (03) :1449-1468
[6]   GUIDE TO ANTICOAGULANT-THERAPY .2. ORAL ANTICOAGULANTS [J].
HIRSH, J ;
FUSTER, V .
CIRCULATION, 1994, 89 (03) :1469-1480
[7]  
RATH B, 1990, BRIT HEART J, V63, P18
[8]  
ROSENZWEIG SM, 1989, COMMENTARY, V87, P2
[9]  
WANG JS, 1994, ANESTH ANAL, V1, P9
[10]   ACTIVATED CLOTTING-TIME VARIABILITY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY [J].
WARNER, MF ;
MIAN, MS ;
MISSRI, JC .
CLINICAL CARDIOLOGY, 1994, 17 (07) :372-374